Iometopane

Drug Profile

Iometopane

Alternative Names: 123I β-CIT; Dopascan; GPI-200; RTI-55

Latest Information Update: 20 Feb 2008

Price : $50

At a glance

  • Originator RTI International
  • Developer Daiichi Radioisotope Labs; MGI GP
  • Class Radiopharmaceutical diagnostics; Small molecules; Tropanes
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Parkinson's disease

Most Recent Events

  • 28 Oct 2005 Guilford Pharmaceuticals is now called MGI GP
  • 05 Oct 2005 Guilford Pharmaceuticals has been acquired by MGI Pharma
  • 23 Aug 2005 Schering AG has terminated the license agreement for iometopane
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top